OSE Immunotherapeutics is a France-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases.
Business Model:
Revenue: $29.8M
Employees: 51-200
Address: 22 Boulevard Benoni Goullin
City: Nantes
State: brittany
Zip: 44200
Country: FR
OSE Immunotherapeutics is a France-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases.
Contact Phone:
Contact Email:
Listed Exchange:
PA
IPO Date:
9/11/2015
Ticker Symbol:
OSE
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2020 | Grant | $228.3k |
Nantes Metropole |
2/2021 | Post-IPO Debt | $30.3M |
European Investment Bank |
6/2017 | Grant | $10.3M | 12/2022 | Post-IPO Debt | $10.6M |
European Investment Bank |
5/2020 | Post-IPO Debt | $7.6M |
Bpifrance BNP Paribas CIC Crédit Mutuel |
12/2020 | Grant | 1 | $6.3M |
Bpifrance Bpifrance Bpifrance Bpifrance |
7/2021 | Debt Financing | 1 | $11.9M |
European Investment Bank European Investment Bank |
12/2016 | Post-IPO Equity | $10.7M | 7/2017 | Grant | 1 | $10.6M |
Bpifrance Bpifrance Bpifrance Bpifrance |
5/2021 | Funding Round | $13M |
---|
Announced Date | Name | Price |
---|---|---|
2/2016 | Effimune SAS |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|